arrow
S

Shinji Takeuchi

Kanazawa University Hospital
H指数:32
被引数:3,616

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary Bronchial Hybrid Low-Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract

原发性支气管混合型低级别纤维黏液样肉瘤/硬化性上皮样纤维肉瘤伴EWSR1::CREB3L1融合:来自呼吸道疑难病例的诊断见解

2026-09-290
OAAI
Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC

奥罗莫西布与帕博利珠单抗联合治疗KRAS G12C突变型晚期非小细胞肺癌的疗效与安全性

2025-11-290
PRE
Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

病例报告: MLH1启动子高甲基化的胰腺髓样癌,诱导错配修复缺陷,用免疫检查点抑制剂成功治疗

2025-03-270
OAAI
A Supramolecular Biosensor for Rapid and High-Throughput Quantification of a Disease-Associated Niacin Metabolite
2024-08-260
PRE
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program
2024-06-011
OAAI
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)

阿来替尼在RET重排的先前治疗的非小细胞肺癌 (ALL-RET) 中的1/2期研究

2021-01-0119
OAAI
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
2020-09-1485
OAAI
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report

减少剂量达拉非尼和曲美替尼联合治疗BRAF V600E-mutant非小细胞肺癌预防横纹肌溶解并维持肿瘤缩小1例报告

2020-02-244
OAAI